USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS

The paper presents a review of an update on the comparative pharmacoeconomic analysis of using dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic evaluation was made to study the use of first-line oral dimethyl fumarate versus another first-line o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev
Formato: Artigo
Idioma:Russo
Publicado em: IMA-PRESS LLC 2016-12-01
Colecção:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Assuntos:
multiple sclerosis
pharmacoeconomics
dimethyl fumarate
teriflunomide
fingolimod
natalizumab
Acesso em linha:https://nnp.ima-press.net/nnp/article/view/681
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados